Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

279
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
279
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

206
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
206
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

473
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
473
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

134
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
134
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

904
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
904
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

964
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
964

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time toxicity of patients with cancer enrolled in clinical trials: a systematic review and meta-analysis.

BMJ supportive & palliative care·2026
Same author

Serial cycle threshold to assess the infectious potential of SARS-CoV-2: A systematic review.

Epidemiology and infection·2026
Same author

Diagnostic accuracy of artificial intelligence-assisted radiology assessment of cancer: a systematic review.

BJR artificial intelligence·2026
Same author

Pivotal studies of pharmacotherapies approved by the US FDA for cancer treatment: a meta-analysis.

The oncologist·2026
Same author

Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta-Analysis.

European journal of neurology·2026
Same author

HASwinNet: A Swin Transformer-Based Denoising Framework with Hybrid Attention for mmWave MIMO Systems.

Entropy (Basel, Switzerland)·2026

Related Experiment Video

Updated: Dec 14, 2025

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

544

Self-management programmes for cirrhosis: A systematic review.

Samuel Boudreault1,2, Junqiao Chen3, Kevin Y Wu4

  • 1Family Medicine Department, Laval University, Quebec, QC, Canada.

Journal of Clinical Nursing
|July 17, 2020
PubMed
Summary

Self-management programs show no proven benefit for improving quality of life or reducing hospitalizations in liver cirrhosis patients. Further research is needed to identify effective program components for this chronic condition.

Keywords:
cirrhosisself-management

More Related Videos

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.1K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K

Related Experiment Videos

Last Updated: Dec 14, 2025

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

544
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

22.1K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K

Area of Science:

  • Hepatology
  • Chronic Disease Management
  • Evidence-Based Medicine

Background:

  • Liver cirrhosis significantly impairs patients' quality of life.
  • Self-management programs (SMPs) have shown success in other chronic diseases.
  • SMPs are proposed to alleviate the burden of liver cirrhosis.

Purpose of the Study:

  • To systematically review and meta-analyze the clinical impact of SMPs in liver cirrhosis patients.
  • To evaluate the effect of SMPs on health-related quality of life (HRQOL) and hospitalizations.

Main Methods:

  • Systematic review and meta-analysis adhering to PRISMA guidelines.
  • Searched multiple databases (MEDLINE, CENTRAL, Embase, CINAHL, PsycINFO) and trial registers.
  • Included four randomized trials with a total of 299 patients, all with high risk of bias.

Main Results:

  • No significant difference in HRQOL or hospitalization days between SMP and control groups.
  • One study showed improved patient knowledge, another showed increased Model for End-Stage Liver Disease (MELD) scores in the SMP group.
  • Low-quality evidence overall; significant variation in SMP content across studies.

Conclusions:

  • Current evidence does not support the benefit of SMPs for individuals with cirrhosis.
  • Caution is advised when implementing SMPs for cirrhosis patients.
  • Further research is essential to define effective SMP features for cirrhosis management.